Press Resease

STD Diagnostics Market - Global Industry Analysis

STD Diagnostics Market by Type (Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing and Others) and by Testing Devices (Laboratory Devices and Point of Care Devices) for Hospitals and Other End Users - Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2026

Published Date: 16-Dec-2016 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-558 Status : Published

According to the report, the STD Diagnostics Market accounted for USD 141.96 Billion in 2019 and is expected to reach USD 248.06 Billion by 2026, growing at a CAGR of around 8.3% between 2020 and 2026.

Description

The report covers forecast and analysis for the STD diagnostics market on a global and regional level. The study provides historic data with a forecast from 2016 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the STD diagnostics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the STD diagnostics market on a global level.

This report offers comprehensive coverage on global STD diagnostics market along with, market trends, drivers, and restraints of STD diagnostics market. This report included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the STD diagnostics market has also been included. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness. This report is prepared using data sourced from in-house databases, secondary and primary research team of industry experts.

The study provides a decisive view on the STD diagnostics market by segmenting the market based on type, end- users, testing device, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The type market covered under this study includes chlamydia testing, syphilis testing, gonorrhea testing, herpes simplex virus testing, human papilloma virus testing, human immunodeficiency virus testing and others. The end-users segmentation includes hospitals and others. The testing device segmentation includes laboratory device and point of care device. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. These regions are further segmented into the U.S., UK, Germany, France, Japan, China, India, and Brazil.  

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global STD diagnostics market include Roche Holdings AG, Abbott Laboratories, Becton Dickinson and Company, Hologic Inc., Danaher Corporation, Affymetrix, bioMerieux, Cepheid Inc., Alere Inc., DiaSorin, and Orasure.

This report segments the global STD diagnostics market as follows:

Global STD Diagnostics Market: Type Analysis

  • Chlamydia testing
  • Syphilis testing
  • Gonorrhea testing
  • Herpes Simplex Virus testing
  • Human Papilloma Virus testing
  • Human Immunodeficiency Virus testing
  • Others

Global STD Diagnostics Market: End- Users Analysis

  • Hospitals
  • Others

Global STD Diagnostics Market: Testing Device Analysis

  • Laboratory Devices
  • Point of Care Devices

Global STD Diagnostics Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • Germany
    • France
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East And Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. STD Diagnostics Market, 2016-2026 (USD Billion)
    • 2.2. STD Diagnostics Market: Snapshot
  • Chapter 3. STD Diagnostics Market - Industry Analysis
    • 3.1. STD Diagnostics Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Rapid Spread Of Human Papilloma Virus (HPV) Infection
    • 3.3. Restraints
      • 3.3.1. Lack Of Education Regarding The Prevalence Of STD Problem
    • 3.4. Opportunity
      • 3.4.1. Covering Untapped Market
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis By Type
      • 3.6.2. Market attractiveness analysis By Testing Device
      • 3.6.3. Market attractiveness analysis By End-User
      • 3.6.4. Market attractiveness analysis by Region
  • Chapter 4. STD Diagnostics Market- Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global STD Diagnostics Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Type launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global STD Diagnostics Market -Type Analysis
    • 5.1. Global STD Diagnostics Market overview: By Type type
      • 5.1.1. Global STD Diagnostics Market share, By Type,2019 and 2026
    • 5.2. Chlamydia Testing
      • 5.2.1. Global STD Diagnostics Market by Chlamydia Testing, 2016-2026 (USD Billion)
    • 5.3. Syphilis Testing
      • 5.3.1. Global STD Diagnostics Market by Syphilis Testing, 2016-2026 (USD Billion)
    • 5.4. Gonorrhea Testing
      • 5.4.1. Global STD Diagnostics Market by Gonorrhea Testing, 2016-2026 (USD Billion)
    • 5.5. Herpes Simplex Virus Testing
      • 5.5.1. Global STD Diagnostics Market by Herpes Simplex Virus Testing, 2016-2026 (USD Billion)
    • 5.6. Human Papilloma Virus Testing
      • 5.6.1. Global STD Diagnostics Market by Human Papilloma Virus Testing, 2016-2026 (USD Billion)
    • 5.7. Human Immunodeficiency Virus Testing
      • 5.7.1. Global STD Diagnostics Market by Human Immunodeficiency Virus Testing, 2016-2026 (USD Billion)
    • 5.8. Others
      • 5.8.1. Global STD Diagnostics Market by others, 2016-2026 (USD Billion)
  • Chapter 6. Global STD Diagnostics Market -Testing Device Analysis
    • 6.1. Global STD Diagnostics Market overview: By Testing Device
      • 6.1.1. Global STD Diagnostics Market share, By Testing Device, 2019 and 2026
    • 6.2. Laboratory Devices
      • 6.2.1. Global STD Diagnostics Market By Laboratory Devices, 2016-2026 (USD Billion)
    • 6.3. Point Of Care Device
      • 6.3.1. Global STD Diagnostics Market By Point Of Care Device, 2016-2026 (USD Billion)
  • Chapter 7. Global STD Diagnostics Market -End-User Analysis
    • 7.1. Global STD Diagnostics Market overview: By End-User
      • 7.1.1. Global STD Diagnostics Market share, By End-User, 2019 and 2026
    • 7.2. Hospitals
      • 7.2.1. Global STD Diagnostics Market by Hospitals, 2016-2026 (USD Billion)
    • 7.3. Others
      • 7.3.1. Global STD Diagnostics Market by others, 2016-2026 (USD Billion)
  • Chapter 8. Global STD Diagnostics Market - Regional Analysis
    • 8.1. Global STD Diagnostics Market overview: by Region
      • 8.1.1. Global STD Diagnostics Marketshare, by Region, 2019 and 2026
    • 8.2. North America
      • 8.2.1. North America STD Diagnostics Market, 2016-2026 (USD Billion)
      • 8.2.2. North America STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
      • 8.2.3. North America STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
      • 8.2.4. North America STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
      • 8.2.5. The U.S.
        • 8.2.5.1. The U.S.STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
        • 8.2.5.2. The U.S.STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
        • 8.2.5.3. The U.S.STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
      • 8.2.6. Rest of North America
        • 8.2.6.1. Rest of North America STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
        • 8.2.6.2. Rest of North America STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
        • 8.2.6.3. Rest of North America STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
    • 8.3. Europe
      • 8.3.1. Europe STD Diagnostics Market, 2016-2026 (USD Billion)
      • 8.3.2. Europe STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
      • 8.3.3. Europe STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
      • 8.3.4. Europe STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
      • 8.3.5. UK
        • 8.3.5.1. U.K.STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
        • 8.3.5.2. U.K.STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
        • 8.3.5.3. U.K. STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
      • 8.3.6. France
        • 8.3.6.1. France STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
        • 8.3.6.2. France STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
        • 8.3.6.3. France STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
      • 8.3.7. Germany
        • 8.3.7.1. Germany STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
        • 8.3.7.2. Germany STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
        • 8.3.7.3. Germany STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
      • 8.3.8. Rest of Europe
        • 8.3.8.1. Rest of EuropeSTD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
        • 8.3.8.2. Rest of EuropeSTD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
        • 8.3.8.3. Rest of Europe STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific STD Diagnostics Market, 2016-2026 (USD Billion)
      • 8.4.2. Asia Pacific STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
      • 8.4.3. Asia Pacific STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
      • 8.4.4. Asia Pacific STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
      • 8.4.5. China
        • 8.4.5.1. China STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
        • 8.4.5.2. China STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
        • 8.4.5.3. China STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
      • 8.4.6. Japan
        • 8.4.6.1. Japan STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
        • 8.4.6.2. Japan STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
        • 8.4.6.3. Japan STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
      • 8.4.7. India
        • 8.4.7.1. India STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
        • 8.4.7.2. India STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
        • 8.4.7.3. India STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
        • 8.4.8.2. Rest of Asia Pacific STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
        • 8.4.8.3. Rest of Asia Pacific STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
    • 8.5. Latin America
      • 8.5.1. Latin America STD Diagnostics Market, 2016-2026 (USD Billion)
      • 8.5.2. Latin America STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
      • 8.5.3. Latin America STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
      • 8.5.4. Latin America STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
        • 8.5.5.2. Brazil STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
        • 8.5.5.3. Brazil STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
      • 8.5.6. Rest of LatinAmerica
        • 8.5.6.1. Rest of LatinAmerica STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
        • 8.5.6.2. Rest of LatinAmerica STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
        • 8.5.6.3. Rest of Latin America STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa STD Diagnostics Market, 2016-2026 (USD Billion)
      • 8.6.2. The Middle East and Africa STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
      • 8.6.3. The Middle East and Africa STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
      • 8.6.4. The Middle East and Africa STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
  • Chapter 9. Company Profiles
    • 9.1. Roche Holdings AG
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Type Portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. Abbott Laboratories
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Type Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. Becton Dickinson and Company
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Type Portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. Hologic Inc.
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Type Portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. Danaher Corporation
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Type Portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Development
    • 9.6. Affymetrix
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Type Portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Development
    • 9.7. bioMerieux
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Type Portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Development
    • 9.8. Cepheid Inc.
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Type Portfolio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Development
    • 9.9. Alere Inc.
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Type Portfolio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Development
    • 9.10. DiaSorin
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Type Portfolio
      • 9.10.4. Business Strategy
      • 9.10.5. Recent Development
    • 9.11. Orasure
      • 9.11.1. Overview
      • 9.11.2. Financials
      • 9.11.3. Type Portfolio
      • 9.11.4. Business Strategy
      • 9.11.5. Recent Development

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global STD Diagnostics market. Zion Research has collected and analyzed key data belong to the global STD Diagnostics market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account while estimating market size. The revenue generated by the leading industry participants in from the sales of STD Diagnostics across the world has been calculated through primary and secondary research.

Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in the validation of findings from secondary research and to understand key trends in the STD Diagnostics industry. Primary research makes up the major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further, develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the STD Diagnostics market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

The term sexually transmitted diseases or STD are commonly used to refer to clinical syndromes and infectious diseases caused by pathogens that can be acquired and transmitted through sexual activity. These infections can easily spread by vaginal or anal intercourse, and sometimes by oral sex. STDs can also spread from the blood of infected patients. In addition, pregnant women with STD’s may pass their infection to infants in the uterus (womb), during birth, or through breast-feeding. Prevention of STD infection is possible by having protective sex (using condoms) or abstaining from the sex.

Globally, STD diagnostics market has been accelerated by the rise in the percentage of unprotected sex which leads to increase in the prevalence of sexually transmitted diseases. Furthermore, lack of awareness coupled with unprotected sex is considered as major governing factors which promote the cause of sexually transmitted diseases and thus STD diagnostic market. Moreover, many lifestyle-related factors, such as having multiple sex partners are estimated to drive the sexual transmitted diseases diagnostic market. However, lack of education, psychological impact and the unwillingness of the infected population to undergo prognosis is expected to hinder the growth of the market. In addition, prevention of infection by vaccination is major restraining factor in a growth of STDs diagnostic market.

Based on the type, the global market of STD diagnostic test is bifurcated into seven types: chlamydia testing, syphilis testing, gonorrhea testing, herpes simplex virus testing, human papiloma virus testing, human immunodeficiency virus testing and others. Global HIV diagnostics market size was approximately USD 2.77 billion in 2019, with a CAGR of 9.5% during the forecast period. The PAP smear tests segment accounted for the largest share of approximately more than 50% of the total HPV testing market in 2019. Factors attributed to its growth due to its lower test prices and growing awareness about the cancer diagnosis. Similarly, the HPV testing market is forecast to grow at the fastest growth rate within the forecast period.

Based on end-user, the global market for STD diagnostic test is bifurcated into two types: hospital and others. In end-user segment, the hospital was the leading segment in 2019 and this segment will remain in continuous growth during the forecast period due to the continuous rise in HPV virus across the globe.

Based on the testing device, the global market for STD diagnostic test is segmented into two major types: laboratory testing device and point of care device. The laboratory testing device market is further sub-segmented into thermal cyclers - PCR, lateral flow readers – immunochromatographic assays, flow cytometers, differential light scattering machines, absorbance microplate reader - Enzyme Linked Immunosorbent Assay (ELISA) and others

Based on geographies, the global market for STD diagnostic is bifurcated into five types: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. These segments are further bifurcated into the U.S., UK, Germany, France, China, Japan, India, and Brazil. North America accounted for the largest share of the global STD diagnostic market followed by Europe. This growth is attributed due to rising awareness related to health care in this region. Moreover, STD diagnostics market has the huge opportunity in the emerging markets of Asia Pacific due to increasing standard of living, large patient base in this region. However, the Asia-Pacific market is projected to grow at the highest CAGR during the forecast period, due to the rising incidence of sexually transmitted diseases, increasing government support, and growing upper middle-class population and rise in disposable income levels in this region.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global STD diagnostics market include Roche Holdings AG, Abbott Laboratories, Becton Dickinson and Company, Hologic Inc., Danaher Corporation, Affymetrix, bioMerieux, Cepheid Inc., Alere Inc., DiaSorin, and Orasure.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social